A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers
Clinical trial NCT06488521 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06488521
- Sponsor
- AO GENERIUM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2025-04-30
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.